ROCKWELL MEDICAL, INC. (RMTI)
Data as of , from SEC Form 4 filings.
See up to 3 months of RMTI. The 7-day demo opens the 1M and 3M ranges and puts RMTI on your watchlist.
Start 7-day demoLatest RMTI insider trades
About ROCKWELL MEDICAL, INC. (RMTI)
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
- WIXOM, MI
- 157
- 1998
- XNAS
RMTI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 1,000 | $8K |
RMTI insider transactions (Form 4)
5046 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John G. Cooper - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Allen Nissenson - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Mark H. Ravich - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Robert S. Radie - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Andrea Heslin Smiley - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
 Timothy Chole - Officer | Grant or award | Common Stock | 85,000 | $0.00 | - | |
| Timothy Chole - Officer | Grant or award | Stock Option (Right to Buy) | 170,000 | $0.00 | - | |
 Jesse Neri - Officer | Grant or award | Common Stock | 97,500 | $0.00 | - | |
| Jesse Neri - Officer | Grant or award | Stock Option (Right to Buy) | 195,000 | $0.00 | - | |
| Megan C. Timmins - Officer | Grant or award | Common Stock | 97,500 | $0.00 | - | |
| Megan C. Timmins - Officer | Grant or award | Stock Option (Right to Buy) | 195,000 | $0.00 | - | |
| Mark Strobeck - Officer | Grant or award | Common Stock | 220,000 | $0.00 | - | |
| Mark Strobeck - Officer | Grant or award | Stock Option (Right to Buy) | 308,000 | $0.00 | - | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 4,000 | $10.60 | $4K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 4,000 | $10.80 | $4K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.51 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.79 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.79 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 6,000 | $10.70 | $6K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.70 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 7,000 | $10.70 | $7K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 10,000 | $11.01 | $11K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.40 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.45 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.49 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.45 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 4,000 | $10.55 | $4K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.56 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.65 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.90 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.80 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 1,000 | $10.89 | $1K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.70 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.75 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.80 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.80 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.80 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 4,000 | $10.90 | $4K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 1,500 | $10.90 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $11.00 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.60 | $2K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 6,000 | $10.80 | $6K | |
| Irrevocable Larson Family Investment Trust - 10% Owner | Open-market purchase | Common Stock | 2,000 | $10.85 | $2K | |
| Mark Strobeck - Officer | Open-market sale | Common Stock | 6,926 | $10.80 | $7K | |
| Jesse Neri - Officer | Open-market sale | Common Stock | 886 | $11.00 | $975 | |
| Timothy Chole - Officer | Open-market sale | Common Stock | 2,868 | $10.80 | $3K | |
| Mark H. Ravich - Director | Open-market sale | Common Stock | 10,000 | $24.00 | $24K | |
| Mark H. Ravich - Director | Open-market sale | Common Stock | 19,991 | $23.20 | $46K | |
| Timothy Chole - Officer | Open-market sale | Common Stock | 1,001 | $36.85 | $4K | |
| Mark Strobeck - Officer | Open-market sale | Common Stock | 2,163 | $36.85 | $8K |
Recent RMTI Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Strobeck Mark | Officer | 1,000 | $8K | View on EDGAR |
RMTI insider trading FAQ
What is the latest insider trade for RMTI?
ROCKWELL MEDICAL, INC. (RMTI) had 1 insider filing in the last 90 days, with the most recent on 2026-10-05. The full record for RMTI runs to 46 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RMTI stock?
No insider purchases of RMTI were filed in the last 90 days. 30 purchases are on record for this company.
How many insiders are selling RMTI stock?
1 insider sale of RMTI was filed in the last 90 days, totaling $8K.
Where can I see RMTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RMTI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark Strobeck view on EDGAR
- - Joseph H. Dawson view on EDGAR
- - Allen Nissenson view on EDGAR
- - Joan Lau view on EDGAR
- - Robert S. Radie view on EDGAR
- - John G. Cooper view on EDGAR
- - Timothy Chole view on EDGAR
- - Heather Hunter view on EDGAR
- - Megan C. Timmins view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where RMTI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RMTI with a 7-day demo
- RMTI on your watchlist
- Every RMTI Form 4 filing on record
- Up to 3 months of RMTI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
